| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | miRNA binding | 7.69e-07 | 48 | 30 | 4 | GO:0035198 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 2.17e-06 | 62 | 30 | 4 | GO:0061980 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.18e-06 | 2 | 30 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | endoribonuclease activity, cleaving miRNA-paired mRNA | 2.18e-06 | 2 | 30 | 2 | GO:0090624 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.18e-06 | 2 | 30 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 5.46e-06 | 78 | 30 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.75e-06 | 79 | 30 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 6.54e-06 | 3 | 30 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 2.22e-05 | 111 | 30 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 4.92e-05 | 136 | 30 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 4.92e-05 | 136 | 30 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.07e-05 | 51 | 30 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.62e-05 | 55 | 30 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 9.88e-05 | 60 | 30 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.31e-04 | 66 | 30 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.31e-04 | 66 | 30 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.16e-04 | 78 | 30 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.26e-04 | 15 | 30 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.65e-04 | 229 | 30 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.78e-04 | 231 | 30 | 4 | GO:0004518 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.50e-04 | 21 | 30 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.75e-04 | 102 | 30 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 5.03e-04 | 104 | 30 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.19e-03 | 140 | 30 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.41e-03 | 37 | 30 | 2 | GO:0016891 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.41e-03 | 37 | 30 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.56e-03 | 39 | 30 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 2.08e-03 | 45 | 30 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.17e-03 | 46 | 30 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.52e-03 | 645 | 30 | 5 | GO:0140640 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.97e-03 | 54 | 30 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 3.08e-03 | 55 | 30 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 3.08e-03 | 55 | 30 | 2 | GO:0051879 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 3.34e-03 | 417 | 30 | 4 | GO:0140098 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 4.03e-03 | 63 | 30 | 2 | GO:0030544 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 4.28e-03 | 65 | 30 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.35e-03 | 238 | 30 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | p53 binding | 5.95e-03 | 77 | 30 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 6.55e-03 | 807 | 30 | 5 | GO:0016788 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 7.05e-03 | 84 | 30 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.37e-03 | 86 | 30 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | protein kinase binding | 9.06e-03 | 873 | 30 | 5 | GO:0019901 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.04e-02 | 303 | 30 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | kinase binding | 1.38e-02 | 969 | 30 | 5 | GO:0019900 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 3.64e-12 | 4 | 30 | 4 | GO:0090625 | |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 3.64e-12 | 4 | 30 | 4 | GO:0140766 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 4.56e-10 | 9 | 30 | 4 | GO:0010501 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 7.59e-10 | 10 | 30 | 4 | GO:0070922 | |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 8.54e-09 | 17 | 30 | 4 | GO:0031054 | |
| GeneOntologyBiologicalProcess | miRNA processing | 6.77e-07 | 48 | 30 | 4 | GO:0035196 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 3.90e-06 | 74 | 30 | 4 | GO:0070918 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.22e-05 | 4 | 30 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | miRNA-mediated gene silencing by inhibition of translation | 1.63e-05 | 106 | 30 | 4 | GO:0035278 | |
| GeneOntologyBiologicalProcess | miRNA-mediated gene silencing by mRNA destabilization | 1.82e-05 | 109 | 30 | 4 | GO:0035279 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 2.57e-05 | 119 | 30 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical NF-kappaB signal transduction | 1.55e-04 | 72 | 30 | 3 | GO:1901224 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 2.16e-04 | 206 | 30 | 4 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 2.37e-04 | 211 | 30 | 4 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 2.37e-04 | 211 | 30 | 4 | GO:0061014 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.42e-04 | 16 | 30 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.42e-04 | 16 | 30 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 3.29e-04 | 230 | 30 | 4 | GO:0017148 | |
| GeneOntologyBiologicalProcess | cellular response to hepatocyte growth factor stimulus | 3.44e-04 | 19 | 30 | 2 | GO:0035729 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.09e-04 | 443 | 30 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 4.11e-04 | 244 | 30 | 4 | GO:0022618 | |
| GeneOntologyBiologicalProcess | response to hepatocyte growth factor | 4.22e-04 | 21 | 30 | 2 | GO:0035728 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 4.29e-04 | 696 | 30 | 6 | GO:0034655 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 4.78e-04 | 254 | 30 | 4 | GO:0071826 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 5.08e-04 | 23 | 30 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 5.08e-04 | 23 | 30 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 5.08e-04 | 23 | 30 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 5.15e-04 | 259 | 30 | 4 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of translation | 6.71e-04 | 494 | 30 | 5 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical NF-kappaB signal transduction | 6.95e-04 | 120 | 30 | 3 | GO:1901222 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 7.55e-04 | 28 | 30 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 8.07e-04 | 292 | 30 | 4 | GO:0043488 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 8.10e-04 | 29 | 30 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 9.26e-04 | 31 | 30 | 2 | GO:0090128 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 9.84e-04 | 308 | 30 | 4 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 9.96e-04 | 309 | 30 | 4 | GO:0061013 | |
| GeneOntologyBiologicalProcess | translation | 1.04e-03 | 824 | 30 | 6 | GO:0006412 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.18e-03 | 35 | 30 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.18e-03 | 35 | 30 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | non-canonical NF-kappaB signal transduction | 1.33e-03 | 150 | 30 | 3 | GO:0038061 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.62e-03 | 41 | 30 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.80e-03 | 917 | 30 | 6 | GO:0016071 | |
| GeneOntologyCellularComponent | RISC-loading complex | 7.19e-10 | 10 | 30 | 4 | GO:0070578 | |
| GeneOntologyCellularComponent | endoribonuclease complex | 2.20e-07 | 37 | 30 | 4 | GO:1902555 | |
| GeneOntologyCellularComponent | endonuclease complex | 4.09e-07 | 43 | 30 | 4 | GO:1905348 | |
| GeneOntologyCellularComponent | P-body | 1.33e-05 | 102 | 30 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 3.66e-04 | 972 | 30 | 7 | GO:0140535 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.65e-04 | 269 | 30 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 7.20e-04 | 287 | 30 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | RISC complex | 2.96e-03 | 422 | 30 | 4 | GO:0016442 | |
| GeneOntologyCellularComponent | RNAi effector complex | 2.99e-03 | 423 | 30 | 4 | GO:0031332 | |
| HumanPheno | Thin upper lip vermilion | 7.48e-07 | 339 | 14 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 7.48e-07 | 339 | 14 | 8 | HP:0000213 | |
| HumanPheno | Juvenile aseptic necrosis | 4.15e-06 | 43 | 14 | 4 | HP:0100323 | |
| HumanPheno | Thin vermilion border | 4.86e-06 | 433 | 14 | 8 | HP:0000233 | |
| HumanPheno | Delayed ability to walk | 6.01e-06 | 304 | 14 | 7 | HP:0031936 | |
| HumanPheno | Plantar crease between first and second toes | 7.02e-06 | 2 | 14 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 7.02e-06 | 2 | 14 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 7.02e-06 | 2 | 14 | 2 | HP:0001042 | |
| HumanPheno | Abnormality of upper lip vermillion | 8.19e-06 | 464 | 14 | 8 | HP:0011339 | |
| HumanPheno | Laryngeal cartilage malformation | 2.10e-05 | 3 | 14 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 2.10e-05 | 3 | 14 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 2.10e-05 | 3 | 14 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 2.10e-05 | 3 | 14 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 2.10e-05 | 3 | 14 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 2.10e-05 | 3 | 14 | 2 | HP:0005895 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 2.14e-05 | 368 | 14 | 7 | HP:0031432 | |
| HumanPheno | Perseverative thought | 2.50e-05 | 377 | 14 | 7 | HP:0030223 | |
| HumanPheno | Disordered formal thought process | 2.92e-05 | 386 | 14 | 7 | HP:0025769 | |
| HumanPheno | Hyperactivity | 3.25e-05 | 558 | 14 | 8 | HP:0000752 | |
| HumanPheno | Abnormal thought pattern | 3.94e-05 | 404 | 14 | 7 | HP:5200269 | |
| HumanPheno | Phonophobia | 4.14e-05 | 26 | 14 | 3 | HP:0002183 | |
| HumanPheno | Trichiasis | 4.20e-05 | 4 | 14 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 4.20e-05 | 4 | 14 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 4.20e-05 | 4 | 14 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 4.20e-05 | 4 | 14 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 4.20e-05 | 4 | 14 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 4.20e-05 | 4 | 14 | 2 | HP:0031207 | |
| HumanPheno | Motor stereotypy | 5.40e-05 | 280 | 14 | 6 | HP:0000733 | |
| HumanPheno | Truncal obesity | 5.52e-05 | 82 | 14 | 4 | HP:0001956 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 6.42e-05 | 30 | 14 | 3 | HP:0005743 | |
| HumanPheno | Abnormal epididymis morphology | 6.42e-05 | 30 | 14 | 3 | HP:0009714 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 6.98e-05 | 5 | 14 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 6.98e-05 | 5 | 14 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 6.98e-05 | 5 | 14 | 2 | HP:0030421 | |
| HumanPheno | Avascular necrosis | 8.69e-05 | 92 | 14 | 4 | HP:0010885 | |
| HumanPheno | Large foramen magnum | 1.05e-04 | 6 | 14 | 2 | HP:0002700 | |
| HumanPheno | Disturbance of facial expression | 1.12e-04 | 36 | 14 | 3 | HP:0005324 | |
| HumanPheno | Auditory sensitivity | 1.22e-04 | 37 | 14 | 3 | HP:0025112 | |
| HumanPheno | Auditory hypersensitivity | 1.22e-04 | 37 | 14 | 3 | HP:5200060 | |
| HumanPheno | Delayed gross motor development | 1.22e-04 | 481 | 14 | 7 | HP:0002194 | |
| HumanPheno | Deviated nasal septum | 1.46e-04 | 7 | 14 | 2 | HP:0004411 | |
| HumanPheno | Wide nasal bridge | 1.73e-04 | 508 | 14 | 7 | HP:0000431 | |
| HumanPheno | Short attention span | 1.94e-04 | 517 | 14 | 7 | HP:0000736 | |
| HumanPheno | Reduced attention regulation | 2.16e-04 | 526 | 14 | 7 | HP:5200044 | |
| HumanPheno | Pilomatrixoma | 2.50e-04 | 9 | 14 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 2.50e-04 | 9 | 14 | 2 | HP:0002341 | |
| HumanPheno | Frontal hirsutism | 3.12e-04 | 10 | 14 | 2 | HP:0011335 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 3.37e-04 | 52 | 14 | 3 | HP:0009834 | |
| HumanPheno | Narrow nasal bridge | 3.57e-04 | 53 | 14 | 3 | HP:0000446 | |
| HumanPheno | Motor delay | 3.72e-04 | 1018 | 14 | 9 | HP:0001270 | |
| HumanPheno | Dislocated radial head | 3.77e-04 | 54 | 14 | 3 | HP:0003083 | |
| HumanPheno | Abnormal subclavian artery morphology | 3.80e-04 | 11 | 14 | 2 | HP:0031251 | |
| HumanPheno | Patent foramen ovale | 3.84e-04 | 135 | 14 | 4 | HP:0001655 | |
| HumanPheno | Low hanging columella | 4.20e-04 | 56 | 14 | 3 | HP:0009765 | |
| HumanPheno | Abnormality of the radial head | 4.43e-04 | 57 | 14 | 3 | HP:0003995 | |
| HumanPheno | Disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 4.71e-04 | 807 | 14 | 8 | HP:0000719 | |
| HumanPheno | Abnormal response to social norms | 4.71e-04 | 807 | 14 | 8 | HP:5200123 | |
| HumanPheno | Social disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:5200029 | |
| HumanPheno | Abnormal scrotum morphology | 4.79e-04 | 143 | 14 | 4 | HP:0000045 | |
| HumanPheno | Deeply set eye | 5.07e-04 | 266 | 14 | 5 | HP:0000490 | |
| HumanPheno | Facial grimacing | 5.38e-04 | 13 | 14 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 5.38e-04 | 13 | 14 | 2 | HP:0010562 | |
| HumanPheno | Impulsivity | 5.60e-04 | 149 | 14 | 4 | HP:0100710 | |
| HumanPheno | Abnormality of the humeroradial joint | 5.68e-04 | 62 | 14 | 3 | HP:0100744 | |
| HumanPheno | Epicanthus | 5.71e-04 | 614 | 14 | 7 | HP:0000286 | |
| HumanPheno | Duplication of phalanx of hallux | 6.26e-04 | 14 | 14 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 6.26e-04 | 14 | 14 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 6.26e-04 | 14 | 14 | 2 | HP:0002697 | |
| HumanPheno | Compulsive behaviors | 6.99e-04 | 158 | 14 | 4 | HP:0000722 | |
| HumanPheno | Duplication of phalanx of toe | 7.22e-04 | 15 | 14 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 7.22e-04 | 15 | 14 | 2 | HP:0007086 | |
| HumanPheno | Abnormally increased volition | 7.93e-04 | 869 | 14 | 8 | HP:5200263 | |
| HumanPheno | Delayed speech and language development | 8.06e-04 | 1123 | 14 | 9 | HP:0000750 | |
| HumanPheno | Square face | 8.23e-04 | 16 | 14 | 2 | HP:0000321 | |
| HumanPheno | Premature thelarche | 9.32e-04 | 17 | 14 | 2 | HP:0010314 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 1.01e-03 | 174 | 14 | 4 | HP:0009832 | |
| HumanPheno | Facial hirsutism | 1.05e-03 | 18 | 14 | 2 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 1.05e-03 | 18 | 14 | 2 | HP:0012842 | |
| HumanPheno | Autistic behavior | 1.05e-03 | 678 | 14 | 7 | HP:0000729 | |
| HumanPheno | Abnormal social development | 1.08e-03 | 908 | 14 | 8 | HP:0025732 | |
| HumanPheno | Sensory hypersensitivity | 1.17e-03 | 319 | 14 | 5 | HP:5200058 | |
| HumanPheno | Language impairment | 1.17e-03 | 1178 | 14 | 9 | HP:0002463 | |
| HumanPheno | Precocious puberty | 1.29e-03 | 186 | 14 | 4 | HP:0000826 | |
| HumanPheno | Absent earlobe | 1.30e-03 | 20 | 14 | 2 | HP:0000387 | |
| HumanPheno | Abnormality of the epiphysis of the femoral head | 1.33e-03 | 83 | 14 | 3 | HP:0010574 | |
| HumanPheno | Persistent left superior vena cava | 1.33e-03 | 83 | 14 | 3 | HP:0005301 | |
| HumanPheno | Early onset of sexual maturation | 1.37e-03 | 189 | 14 | 4 | HP:0100000 | |
| HumanPheno | Elbow dislocation | 1.38e-03 | 84 | 14 | 3 | HP:0003042 | |
| HumanPheno | Abnormal superior vena cava morphology | 1.43e-03 | 85 | 14 | 3 | HP:0025575 | |
| HumanPheno | Localized hirsutism | 1.43e-03 | 21 | 14 | 2 | HP:0009889 | |
| HumanPheno | Deep plantar creases | 1.43e-03 | 21 | 14 | 2 | HP:0001869 | |
| HumanPheno | Corneal scarring | 1.43e-03 | 21 | 14 | 2 | HP:0000559 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 1.48e-03 | 86 | 14 | 3 | HP:0006499 | |
| HumanPheno | Sensory behavioral abnormality | 1.50e-03 | 337 | 14 | 5 | HP:5200046 | |
| HumanPheno | Aggressive behavior | 1.55e-03 | 516 | 14 | 6 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.55e-03 | 516 | 14 | 6 | HP:0006919 | |
| HumanPheno | Abnormal vena cava morphology | 1.58e-03 | 88 | 14 | 3 | HP:0030971 | |
| HumanPheno | Abnormal vena cava morphology | 1.63e-03 | 89 | 14 | 3 | HP:0005345 | |
| HumanPheno | Broad thumb | 1.69e-03 | 90 | 14 | 3 | HP:0011304 | |
| Domain | Argonaute_N | 4.04e-12 | 4 | 28 | 4 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 4.04e-12 | 4 | 28 | 4 | IPR032473 | |
| Domain | ArgoL2 | 4.04e-12 | 4 | 28 | 4 | IPR032472 | |
| Domain | ArgoN | 4.04e-12 | 4 | 28 | 4 | PF16486 | |
| Domain | ArgoMid | 4.04e-12 | 4 | 28 | 4 | PF16487 | |
| Domain | ArgoL2 | 4.04e-12 | 4 | 28 | 4 | PF16488 | |
| Domain | DUF1785 | 2.02e-11 | 5 | 28 | 4 | SM01163 | |
| Domain | ArgoL1 | 6.05e-11 | 6 | 28 | 4 | PF08699 | |
| Domain | ArgoL1 | 6.05e-11 | 6 | 28 | 4 | IPR014811 | |
| Domain | PIWI | 2.82e-10 | 8 | 28 | 4 | PS50822 | |
| Domain | Piwi | 2.82e-10 | 8 | 28 | 4 | IPR003165 | |
| Domain | Piwi | 2.82e-10 | 8 | 28 | 4 | PF02171 | |
| Domain | Piwi | 2.82e-10 | 8 | 28 | 4 | SM00950 | |
| Domain | PAZ | 5.06e-10 | 9 | 28 | 4 | PS50821 | |
| Domain | PAZ_dom | 5.06e-10 | 9 | 28 | 4 | IPR003100 | |
| Domain | PAZ | 5.06e-10 | 9 | 28 | 4 | PF02170 | |
| Domain | PAZ | 5.06e-10 | 9 | 28 | 4 | SM00949 | |
| Domain | - | 7.63e-09 | 47 | 28 | 5 | 3.30.420.10 | |
| Domain | RNaseH-like_dom | 5.46e-08 | 69 | 28 | 5 | IPR012337 | |
| Domain | - | 2.17e-06 | 2 | 28 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.17e-06 | 2 | 28 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.17e-06 | 2 | 28 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.17e-06 | 2 | 28 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.17e-06 | 2 | 28 | 2 | PF08214 | |
| Domain | KIX | 2.17e-06 | 2 | 28 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 2.17e-06 | 2 | 28 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.17e-06 | 2 | 28 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.17e-06 | 2 | 28 | 2 | IPR013178 | |
| Domain | DUF902 | 2.17e-06 | 2 | 28 | 2 | PF06001 | |
| Domain | - | 2.17e-06 | 2 | 28 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.17e-06 | 2 | 28 | 2 | IPR010303 | |
| Domain | KAT11 | 2.17e-06 | 2 | 28 | 2 | SM01250 | |
| Domain | - | 2.17e-06 | 2 | 28 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 2.17e-06 | 2 | 28 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.17e-06 | 2 | 28 | 2 | IPR003101 | |
| Domain | Creb_binding | 2.17e-06 | 2 | 28 | 2 | PF09030 | |
| Domain | KIX | 2.17e-06 | 2 | 28 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 2.17e-06 | 2 | 28 | 2 | PS51727 | |
| Domain | Nuc_rcpt_coact | 3.24e-05 | 6 | 28 | 2 | IPR009110 | |
| Domain | ZF_ZZ_2 | 3.27e-04 | 18 | 28 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.27e-04 | 18 | 28 | 2 | PS01357 | |
| Domain | ZZ | 3.27e-04 | 18 | 28 | 2 | PF00569 | |
| Domain | Znf_ZZ | 3.65e-04 | 19 | 28 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.65e-04 | 19 | 28 | 2 | SM00291 | |
| Domain | Bromodomain_CS | 6.89e-04 | 26 | 28 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.40e-03 | 37 | 28 | 2 | PS00633 | |
| Domain | Bromodomain | 1.47e-03 | 38 | 28 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.71e-03 | 41 | 28 | 2 | PS50014 | |
| Domain | BROMO | 1.80e-03 | 42 | 28 | 2 | SM00297 | |
| Domain | Bromodomain | 1.80e-03 | 42 | 28 | 2 | IPR001487 | |
| Domain | - | 1.80e-03 | 42 | 28 | 2 | 1.20.920.10 | |
| Domain | IQ | 5.05e-03 | 71 | 28 | 2 | PF00612 | |
| Domain | IQ | 6.53e-03 | 81 | 28 | 2 | SM00015 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 3.23e-11 | 5 | 24 | 4 | M22079 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 9.67e-11 | 6 | 24 | 4 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 9.67e-11 | 6 | 24 | 4 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.25e-10 | 7 | 24 | 4 | M46421 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 4.50e-10 | 8 | 24 | 4 | MM15082 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 8.09e-10 | 9 | 24 | 4 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 8.09e-10 | 9 | 24 | 4 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 8.09e-10 | 9 | 24 | 4 | M46436 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 8.78e-10 | 28 | 24 | 5 | M48253 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.35e-09 | 10 | 24 | 4 | M48013 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.47e-09 | 34 | 24 | 5 | M46422 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 3.86e-09 | 37 | 24 | 5 | M29790 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 4.57e-09 | 13 | 24 | 4 | M46434 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.34e-08 | 47 | 24 | 5 | M29777 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.52e-08 | 17 | 24 | 4 | M27788 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.66e-08 | 49 | 24 | 5 | M48250 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 2.46e-08 | 19 | 24 | 4 | M48238 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.79e-08 | 119 | 24 | 6 | M607 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 7.98e-08 | 25 | 24 | 4 | M712 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.45e-07 | 149 | 24 | 6 | M27888 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.25e-07 | 32 | 24 | 4 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.25e-07 | 32 | 24 | 4 | M27900 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 3.27e-07 | 35 | 24 | 4 | M42525 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.30e-06 | 49 | 24 | 4 | MM14837 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.44e-06 | 220 | 24 | 6 | M27794 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.21e-06 | 237 | 24 | 6 | M27786 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.58e-06 | 58 | 24 | 4 | M11980 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.75e-06 | 246 | 24 | 6 | M10189 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.95e-06 | 137 | 24 | 5 | M48232 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.37e-06 | 62 | 24 | 4 | M27321 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 3.60e-06 | 63 | 24 | 4 | M27862 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.51e-06 | 161 | 24 | 5 | M27871 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 7.97e-06 | 296 | 24 | 6 | M27869 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.14e-05 | 84 | 24 | 4 | M27495 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.48e-05 | 330 | 24 | 6 | M7847 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.50e-05 | 90 | 24 | 4 | M820 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.70e-05 | 93 | 24 | 4 | M27572 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 1.70e-05 | 93 | 24 | 4 | M42521 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.85e-05 | 95 | 24 | 4 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.93e-05 | 96 | 24 | 4 | M27792 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.43e-05 | 360 | 24 | 6 | M27267 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.74e-05 | 35 | 24 | 3 | M27190 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.77e-05 | 5 | 24 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.77e-05 | 5 | 24 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.77e-05 | 5 | 24 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.77e-05 | 5 | 24 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.15e-05 | 6 | 24 | 2 | M22062 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 4.21e-05 | 117 | 24 | 4 | M19248 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.43e-05 | 41 | 24 | 3 | M29748 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.80e-05 | 7 | 24 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.73e-05 | 8 | 24 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 7.73e-05 | 8 | 24 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 7.73e-05 | 8 | 24 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 7.73e-05 | 8 | 24 | 2 | M46443 | |
| Pathway | REACTOME_PTEN_REGULATION | 8.25e-05 | 139 | 24 | 4 | M27646 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 8.25e-05 | 139 | 24 | 4 | M715 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 9.93e-05 | 9 | 24 | 2 | M47451 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 9.99e-05 | 146 | 24 | 4 | M27288 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 1.00e-04 | 464 | 24 | 6 | M27547 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.24e-04 | 10 | 24 | 2 | M27945 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.26e-04 | 155 | 24 | 4 | M522 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.51e-04 | 11 | 24 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.51e-04 | 11 | 24 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.51e-04 | 11 | 24 | 2 | M26924 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.77e-04 | 65 | 24 | 3 | M39682 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.81e-04 | 12 | 24 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.81e-04 | 12 | 24 | 2 | M27765 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.85e-04 | 66 | 24 | 3 | M255 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.50e-04 | 14 | 24 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.88e-04 | 15 | 24 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.88e-04 | 15 | 24 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.29e-04 | 16 | 24 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.29e-04 | 16 | 24 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.29e-04 | 16 | 24 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 3.72e-04 | 17 | 24 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.72e-04 | 17 | 24 | 2 | M48025 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 4.04e-04 | 86 | 24 | 3 | M39375 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 4.18e-04 | 18 | 24 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.67e-04 | 19 | 24 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 4.67e-04 | 19 | 24 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.18e-04 | 20 | 24 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 5.72e-04 | 21 | 24 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 5.72e-04 | 21 | 24 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.28e-04 | 22 | 24 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.28e-04 | 22 | 24 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.88e-04 | 23 | 24 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.49e-04 | 24 | 24 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.14e-04 | 25 | 24 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M32 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.02e-03 | 28 | 24 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.17e-03 | 30 | 24 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.17e-03 | 30 | 24 | 2 | M936 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.20e-03 | 125 | 24 | 3 | M27186 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.29e-03 | 128 | 24 | 3 | M48019 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.34e-03 | 32 | 24 | 2 | M39521 | |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 4.50e-13 | 4 | 30 | 4 | 23748378 | |
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 4.50e-13 | 4 | 30 | 4 | 22795694 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 4.50e-13 | 4 | 30 | 4 | 15260970 | |
| Pubmed | 4.50e-13 | 4 | 30 | 4 | 19966796 | ||
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 4.50e-13 | 4 | 30 | 4 | 18771919 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 12526743 | ||
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 19393748 | ||
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 19324964 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 2.25e-12 | 5 | 30 | 4 | 16036130 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 12414724 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 34907157 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 19536157 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.57e-11 | 7 | 30 | 4 | 19470757 | |
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 3.14e-11 | 8 | 30 | 4 | 19345100 | |
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 29021386 | ||
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 5.65e-11 | 9 | 30 | 4 | 12906857 | |
| Pubmed | Turning catalytically inactive human Argonaute proteins into active slicer enzymes. | 5.79e-10 | 3 | 30 | 3 | 23665583 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 10347196 | ||
| Pubmed | The roles of individual mammalian argonautes in RNA interference in vivo. | 5.79e-10 | 3 | 30 | 3 | 24992693 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 15284456 | ||
| Pubmed | Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. | 5.79e-10 | 3 | 30 | 3 | 19946268 | |
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 8.12e-10 | 16 | 30 | 4 | 20102707 | |
| Pubmed | Argonaute proteins: potential biomarkers for human colon cancer. | 2.32e-09 | 4 | 30 | 3 | 20146808 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 11581372 | ||
| Pubmed | A Requirement for Argonaute 4 in Mammalian Antiviral Defense. | 2.32e-09 | 4 | 30 | 3 | 32049003 | |
| Pubmed | Quantitative functions of Argonaute proteins in mammalian development. | 5.78e-09 | 5 | 30 | 3 | 22474261 | |
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 28683311 | ||
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 9.51e-08 | 11 | 30 | 3 | 22915799 | |
| Pubmed | 1.88e-07 | 1429 | 30 | 10 | 35140242 | ||
| Pubmed | 2.72e-07 | 1116 | 30 | 9 | 31753913 | ||
| Pubmed | 5.53e-07 | 76 | 30 | 4 | 27542412 | ||
| Pubmed | 6.80e-07 | 80 | 30 | 4 | 35803934 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27881875 | ||
| Pubmed | Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. | 7.19e-07 | 2 | 30 | 2 | 23019594 | |
| Pubmed | Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. | 7.19e-07 | 2 | 30 | 2 | 16936728 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 7.19e-07 | 2 | 30 | 2 | 11963968 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 7.19e-07 | 2 | 30 | 2 | 34845315 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10534406 | ||
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 7.19e-07 | 2 | 30 | 2 | 34813504 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26242502 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19729597 | ||
| Pubmed | Argonaute Family Protein Expression in Normal Tissue and Cancer Entities. | 7.19e-07 | 2 | 30 | 2 | 27518285 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15860545 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 7.19e-07 | 2 | 30 | 2 | 12696060 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29460469 | ||
| Pubmed | Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection. | 7.19e-07 | 2 | 30 | 2 | 22318144 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20301699 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 7.19e-07 | 2 | 30 | 2 | 24551300 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33233493 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 7.19e-07 | 2 | 30 | 2 | 36109165 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24639469 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 37816914 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12242694 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33911074 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9018065 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24648406 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30135524 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 7.19e-07 | 2 | 30 | 2 | 11438528 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10918613 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31182547 | ||
| Pubmed | Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA. | 7.19e-07 | 2 | 30 | 2 | 33122430 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35502657 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 39287984 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30635043 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31898871 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 7.19e-07 | 2 | 30 | 2 | 16596650 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 7.19e-07 | 2 | 30 | 2 | 27648933 | |
| Pubmed | Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population. | 7.19e-07 | 2 | 30 | 2 | 36142498 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 7.19e-07 | 2 | 30 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 7.19e-07 | 2 | 30 | 2 | 27881443 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 7.19e-07 | 2 | 30 | 2 | 29217654 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19272189 | ||
| Pubmed | Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. | 7.19e-07 | 2 | 30 | 2 | 22858679 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 7.19e-07 | 2 | 30 | 2 | 37314181 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20717166 | ||
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 7.19e-07 | 2 | 30 | 2 | 12397173 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10049825 | ||
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 7.19e-07 | 2 | 30 | 2 | 15641773 | |
| Pubmed | Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. | 7.19e-07 | 2 | 30 | 2 | 12230974 | |
| Pubmed | Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss. | 7.19e-07 | 2 | 30 | 2 | 31666609 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 7.19e-07 | 2 | 30 | 2 | 32690000 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9733868 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30953353 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21803292 | ||
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 7.19e-07 | 2 | 30 | 2 | 22265015 | |
| Pubmed | Effects of Echinococcus multilocularis miR-71 mimics on murine macrophage RAW264.7 cells. | 7.19e-07 | 2 | 30 | 2 | 26995025 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9811832 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 7.19e-07 | 2 | 30 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 7.19e-07 | 2 | 30 | 2 | 29170789 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24089570 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25893291 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11559821 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21555743 | ||
| Pubmed | Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases. | 7.19e-07 | 2 | 30 | 2 | 29256262 | |
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 7.19e-07 | 2 | 30 | 2 | 33063428 | |
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 7.19e-07 | 2 | 30 | 2 | 12646247 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34506759 | ||
| Interaction | TDRD1 interactions | 1.52e-08 | 19 | 30 | 4 | int:TDRD1 | |
| Interaction | TRIM24 interactions | 8.63e-08 | 398 | 30 | 8 | int:TRIM24 | |
| Interaction | HSP90AB4P interactions | 1.11e-06 | 126 | 30 | 5 | int:HSP90AB4P | |
| Interaction | BMI1 interactions | 3.88e-06 | 659 | 30 | 8 | int:BMI1 | |
| Interaction | MARK1 interactions | 4.27e-06 | 74 | 30 | 4 | int:MARK1 | |
| Interaction | ATOH1 interactions | 5.83e-06 | 80 | 30 | 4 | int:ATOH1 | |
| Interaction | FAM120C interactions | 8.53e-06 | 191 | 30 | 5 | int:FAM120C | |
| Interaction | RBMS1 interactions | 1.26e-05 | 207 | 30 | 5 | int:RBMS1 | |
| Interaction | CITED1 interactions | 2.24e-05 | 37 | 30 | 3 | int:CITED1 | |
| Interaction | TARBP2 interactions | 4.10e-05 | 131 | 30 | 4 | int:TARBP2 | |
| Interaction | MARK2 interactions | 4.83e-05 | 274 | 30 | 5 | int:MARK2 | |
| Interaction | TNRC6C interactions | 5.02e-05 | 138 | 30 | 4 | int:TNRC6C | |
| Interaction | PUM1 interactions | 6.02e-05 | 287 | 30 | 5 | int:PUM1 | |
| Interaction | DAZL interactions | 6.09e-05 | 145 | 30 | 4 | int:DAZL | |
| Interaction | CELF1 interactions | 6.12e-05 | 288 | 30 | 5 | int:CELF1 | |
| Interaction | HES6 interactions | 6.26e-05 | 52 | 30 | 3 | int:HES6 | |
| Interaction | DECR2 interactions | 7.01e-05 | 54 | 30 | 3 | int:DECR2 | |
| Interaction | PEX5L interactions | 7.01e-05 | 54 | 30 | 3 | int:PEX5L | |
| Interaction | AGO3 interactions | 7.51e-05 | 153 | 30 | 4 | int:AGO3 | |
| Interaction | HOXB3 interactions | 7.66e-05 | 9 | 30 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 7.66e-05 | 9 | 30 | 2 | int:ARGFX | |
| Interaction | KLF4 interactions | 8.93e-05 | 160 | 30 | 4 | int:KLF4 | |
| Interaction | HOXB6 interactions | 9.62e-05 | 60 | 30 | 3 | int:HOXB6 | |
| Interaction | TP73 interactions | 1.10e-04 | 169 | 30 | 4 | int:TP73 | |
| Interaction | PATL1 interactions | 1.32e-04 | 177 | 30 | 4 | int:PATL1 | |
| Interaction | CNOT2 interactions | 1.35e-04 | 178 | 30 | 4 | int:CNOT2 | |
| Interaction | DICER1 interactions | 1.44e-04 | 181 | 30 | 4 | int:DICER1 | |
| Interaction | ZFP36 interactions | 1.44e-04 | 181 | 30 | 4 | int:ZFP36 | |
| Interaction | TMEFF2 interactions | 1.65e-04 | 13 | 30 | 2 | int:TMEFF2 | |
| Interaction | KAT5 interactions | 1.70e-04 | 358 | 30 | 5 | int:KAT5 | |
| Interaction | IPO8 interactions | 1.77e-04 | 191 | 30 | 4 | int:IPO8 | |
| Interaction | GPBP1 interactions | 1.87e-04 | 75 | 30 | 3 | int:GPBP1 | |
| Interaction | CTIF interactions | 2.02e-04 | 77 | 30 | 3 | int:CTIF | |
| Interaction | SEMA3B interactions | 2.10e-04 | 78 | 30 | 3 | int:SEMA3B | |
| Interaction | E2F1 interactions | 2.11e-04 | 200 | 30 | 4 | int:E2F1 | |
| Interaction | HSF2 interactions | 2.18e-04 | 79 | 30 | 3 | int:HSF2 | |
| Interaction | CIMAP1D interactions | 2.22e-04 | 15 | 30 | 2 | int:CIMAP1D | |
| Interaction | KLF2 interactions | 2.22e-04 | 15 | 30 | 2 | int:KLF2 | |
| Interaction | MKRN2 interactions | 2.38e-04 | 385 | 30 | 5 | int:MKRN2 | |
| Interaction | SOX7 interactions | 2.44e-04 | 82 | 30 | 3 | int:SOX7 | |
| Interaction | SRA1 interactions | 2.52e-04 | 83 | 30 | 3 | int:SRA1 | |
| Interaction | SP3 interactions | 2.61e-04 | 84 | 30 | 3 | int:SP3 | |
| Interaction | H2AC25 interactions | 2.61e-04 | 84 | 30 | 3 | int:H2AC25 | |
| Interaction | MAML2 interactions | 2.87e-04 | 17 | 30 | 2 | int:MAML2 | |
| Interaction | HNRNPC interactions | 2.95e-04 | 634 | 30 | 6 | int:HNRNPC | |
| Interaction | MEX3B interactions | 3.14e-04 | 222 | 30 | 4 | int:MEX3B | |
| Interaction | DYRK1B interactions | 3.31e-04 | 91 | 30 | 3 | int:DYRK1B | |
| Interaction | CNOT6L interactions | 3.53e-04 | 93 | 30 | 3 | int:CNOT6L | |
| Interaction | HSP90AA5P interactions | 3.53e-04 | 93 | 30 | 3 | int:HSP90AA5P | |
| Interaction | NEUROG1 interactions | 3.61e-04 | 19 | 30 | 2 | int:NEUROG1 | |
| Interaction | CTR9 interactions | 3.77e-04 | 233 | 30 | 4 | int:CTR9 | |
| Interaction | SPIB interactions | 4.00e-04 | 20 | 30 | 2 | int:SPIB | |
| Interaction | TP53BP2 interactions | 4.28e-04 | 241 | 30 | 4 | int:TP53BP2 | |
| Interaction | HOXB4 interactions | 4.42e-04 | 21 | 30 | 2 | int:HOXB4 | |
| Interaction | PLAGL1 interactions | 4.42e-04 | 21 | 30 | 2 | int:PLAGL1 | |
| Interaction | KLF13 interactions | 4.42e-04 | 21 | 30 | 2 | int:KLF13 | |
| Interaction | CITED4 interactions | 4.42e-04 | 21 | 30 | 2 | int:CITED4 | |
| Interaction | GAPDH interactions | 4.49e-04 | 686 | 30 | 6 | int:GAPDH | |
| Interaction | MARK3 interactions | 4.63e-04 | 246 | 30 | 4 | int:MARK3 | |
| Interaction | MOV10 interactions | 4.70e-04 | 1297 | 30 | 8 | int:MOV10 | |
| Interaction | DDB1 interactions | 4.89e-04 | 697 | 30 | 6 | int:DDB1 | |
| Interaction | CITED2 interactions | 5.32e-04 | 23 | 30 | 2 | int:CITED2 | |
| Interaction | HOXD10 interactions | 5.32e-04 | 23 | 30 | 2 | int:HOXD10 | |
| Interaction | HELZ interactions | 5.45e-04 | 257 | 30 | 4 | int:HELZ | |
| Interaction | CNTN2 interactions | 5.79e-04 | 24 | 30 | 2 | int:CNTN2 | |
| Interaction | NR6A1 interactions | 5.79e-04 | 24 | 30 | 2 | int:NR6A1 | |
| Interaction | TBX21 interactions | 5.79e-04 | 24 | 30 | 2 | int:TBX21 | |
| Interaction | AGO2 interactions | 6.06e-04 | 472 | 30 | 5 | int:AGO2 | |
| Interaction | ALX1 interactions | 6.29e-04 | 25 | 30 | 2 | int:ALX1 | |
| Interaction | HNRNPU interactions | 6.64e-04 | 1035 | 30 | 7 | int:HNRNPU | |
| Interaction | HOXB7 interactions | 6.81e-04 | 26 | 30 | 2 | int:HOXB7 | |
| Interaction | PGAM5 interactions | 6.93e-04 | 274 | 30 | 4 | int:PGAM5 | |
| Interaction | AGO4 interactions | 7.08e-04 | 118 | 30 | 3 | int:AGO4 | |
| Interaction | KIF20A interactions | 7.31e-04 | 1052 | 30 | 7 | int:KIF20A | |
| Interaction | KBTBD8 interactions | 7.35e-04 | 27 | 30 | 2 | int:KBTBD8 | |
| Interaction | TNRC6A interactions | 7.52e-04 | 280 | 30 | 4 | int:TNRC6A | |
| Interaction | ETS1 interactions | 7.61e-04 | 121 | 30 | 3 | int:ETS1 | |
| Interaction | TNRC6B interactions | 7.72e-04 | 282 | 30 | 4 | int:TNRC6B | |
| Interaction | DDX6 interactions | 8.08e-04 | 503 | 30 | 5 | int:DDX6 | |
| Interaction | PCBP2 interactions | 8.35e-04 | 288 | 30 | 4 | int:PCBP2 | |
| Interaction | SRCAP interactions | 8.76e-04 | 127 | 30 | 3 | int:SRCAP | |
| Interaction | SLC1A4 interactions | 9.08e-04 | 30 | 30 | 2 | int:SLC1A4 | |
| Interaction | HOXD4 interactions | 9.08e-04 | 30 | 30 | 2 | int:HOXD4 | |
| Interaction | R3HDM2 interactions | 9.17e-04 | 129 | 30 | 3 | int:R3HDM2 | |
| Interaction | FUBP3 interactions | 9.36e-04 | 297 | 30 | 4 | int:FUBP3 | |
| Interaction | UBAP2L interactions | 9.48e-04 | 298 | 30 | 4 | int:UBAP2L | |
| Interaction | FBXL9P interactions | 9.70e-04 | 31 | 30 | 2 | int:FBXL9P | |
| Interaction | CRTC1 interactions | 9.70e-04 | 31 | 30 | 2 | int:CRTC1 | |
| Interaction | EIF4ENIF1 interactions | 9.72e-04 | 300 | 30 | 4 | int:EIF4ENIF1 | |
| Interaction | MYB interactions | 1.00e-03 | 133 | 30 | 3 | int:MYB | |
| Interaction | NEUROD1 interactions | 1.03e-03 | 32 | 30 | 2 | int:NEUROD1 | |
| Interaction | PPARG interactions | 1.06e-03 | 307 | 30 | 4 | int:PPARG | |
| Interaction | TRERF1 interactions | 1.10e-03 | 33 | 30 | 2 | int:TRERF1 | |
| Interaction | YTHDF2 interactions | 1.12e-03 | 312 | 30 | 4 | int:YTHDF2 | |
| Interaction | HNRNPH2 interactions | 1.12e-03 | 312 | 30 | 4 | int:HNRNPH2 | |
| Interaction | CNOT7 interactions | 1.16e-03 | 140 | 30 | 3 | int:CNOT7 | |
| Interaction | HAND2 interactions | 1.17e-03 | 34 | 30 | 2 | int:HAND2 | |
| Interaction | ANKS1B interactions | 1.17e-03 | 34 | 30 | 2 | int:ANKS1B | |
| Interaction | NCOA2 interactions | 1.19e-03 | 141 | 30 | 3 | int:NCOA2 | |
| Interaction | C3orf62 interactions | 1.24e-03 | 35 | 30 | 2 | int:C3orf62 | |
| Cytoband | 1p34 | 2.02e-04 | 32 | 30 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 9.29e-04 | 294 | 30 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.59e-03 | 355 | 30 | 3 | chr8q24 | |
| GeneFamily | Argonaute/PIWI family | 1.15e-10 | 8 | 22 | 4 | 408 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.90e-04 | 17 | 22 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.14e-04 | 18 | 22 | 2 | 91 | |
| GeneFamily | RNA binding motif containing | 2.73e-02 | 213 | 22 | 2 | 725 | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; HL60; HG-U133A | 4.74e-06 | 198 | 29 | 5 | 1579_UP | |
| Disease | Menke-Hennekam syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 9.99e-07 | 2 | 30 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 9.99e-07 | 2 | 30 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 1.43e-04 | 100 | 30 | 3 | C0010606 | |
| Disease | congestive heart failure (is_implicated_in) | 3.45e-04 | 27 | 30 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 3.72e-04 | 28 | 30 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 3.86e-04 | 140 | 30 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.95e-04 | 141 | 30 | 3 | C0005684 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 7.23e-04 | 39 | 30 | 2 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | epilepsy | 7.99e-04 | 41 | 30 | 2 | EFO_0000474 | |
| Disease | Carcinoma, Transitional Cell | 7.99e-04 | 41 | 30 | 2 | C0007138 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.18e-03 | 206 | 30 | 3 | C0152013 | |
| Disease | Small cell carcinoma of lung | 1.38e-03 | 54 | 30 | 2 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.44e-03 | 55 | 30 | 2 | C0079744 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.44e-03 | 55 | 30 | 2 | DOID:9952 (is_implicated_in) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.76e-03 | 61 | 30 | 2 | C1961102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKRVVQHTKGCKRKT | 1761 | Q09472 | |
| KIKMRIGHTVAKQVY | 2556 | Q96N23 | |
| MHKRERTCKDYIKAV | 606 | O94910 | |
| EVTHCGQMKRKYRVC | 266 | Q9UL18 | |
| QKMKRVVQHTKGCKR | 1796 | Q92793 | |
| LKVEVTHCGTMRRKY | 266 | Q9H9G7 | |
| KVEVTHCGQMKRKYR | 256 | Q9HCK5 | |
| RQTAHCIKKGRGMVK | 846 | P58397 | |
| KVEITHCGQMKRKYR | 266 | Q9UKV8 | |
| FGKRRYICMKAIKNH | 1091 | Q6IQ32 | |
| IRERKMRQHYKSCKV | 486 | A0A1B0GVH7 | |
| VHGKVLLMQKYRRCG | 231 | Q8WVB3 | |
| RSGKKRTVEMHNKIY | 546 | P19367 | |
| GQVIHKRCEEMKYCK | 11 | Q8NB16 | |
| KCGRRKKGQQYDMVL | 536 | Q92819 | |
| QKRYRGHKITHKMIC | 546 | P03951 | |
| ERKKVIQHIRGMYKV | 2901 | Q99698 | |
| KYCKKVFGTHTNMRR | 486 | Q13029 | |
| VMNKYKVHGKEILRT | 256 | O14830 | |
| CRHMGTKEEFVKVRK | 11 | O75031 | |
| AAMKKYCKVIRVIVH | 151 | Q92901 | |
| KVHNYCNMKKSRLGR | 26 | Q06250 | |
| QRCHKKVMKERYVEV | 536 | Q9H6T0 | |
| EKQMPKKYEHVIRCR | 846 | Q6ZRS2 | |
| VDRMHKGVAYVKRKI | 1016 | P35498 | |
| QGIYMVYCRKHKKTA | 121 | Q8IWS0 | |
| KSKHGKQRAEYMRIQ | 1121 | Q9C0H9 | |
| VYGDVHRVKIMFNKK | 381 | O95758 | |
| HYKKRCQGRMRKHVG | 196 | Q96Q05 | |
| KHDCVGYVMKKAPVR | 766 | P51784 |